Cibc World Markets Cut Its Pfizer (PFE) Stake; JMP Group Has 1.29 Sentiment

January 14, 2018 - By Louis Casey

JMP Group LLC, together with its subsidiaries, provides investment banking, sales and trading, equity research, and asset management services in the United States. The company has market cap of $117.96 million. It operates through three divisions: Broker-Dealer, Asset Management, and Corporate divisions. It currently has negative earnings. The Broker-Dealer segment offers services, such as underwriting and acting as a placement agent for public and private capital markets raising transactions; and financial advisory services in mergers and acquisitions, restructuring, and other strategic transactions.

Cibc World Markets Inc decreased Pfizer Inc (PFE) stake by 1.85% reported in 2017Q3 SEC filing. Cibc World Markets Inc sold 23,647 shares as Pfizer Inc (PFE)’s stock declined 3.45%. The Cibc World Markets Inc holds 1.25 million shares with $44.76M value, down from 1.28M last quarter. Pfizer Inc now has $217.80 billion valuation. The stock decreased 0.05% or $0.02 during the last trading session, reaching $36.54. About 19.20M shares traded or 25.61% up from the average. Pfizer Inc. (NYSE:PFE) has declined 2.76% since January 14, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Continental Advisors Llc holds 0.38% of its portfolio in JMP Group LLC for 295,326 shares. Zpr Investment Management owns 16,517 shares or 0.14% of their US portfolio. Moreover, Hilltop Holdings Inc. has 0.09% invested in the company for 50,100 shares. The Massachusetts-based Essex Investment Management Co Llc has invested 0.04% in the stock. Arbiter Partners Capital Management Llc, a New York-based fund reported 23,589 shares.

The stock decreased 0.18% or $0.01 during the last trading session, reaching $5.49. About 14,492 shares traded. JMP Group LLC (JMP) has risen 2.86% since January 14, 2017 and is uptrending. It has underperformed by 13.84% the S&P500.

Analysts await JMP Group LLC (NYSE:JMP) to report earnings on February, 21. They expect $0.46 earnings per share, up 253.85% or $0.33 from last year’s $0.13 per share. JMP’s profit will be $9.88M for 2.98 P/E if the $0.46 EPS becomes a reality. After $0.10 actual earnings per share reported by JMP Group LLC for the previous quarter, Wall Street now forecasts 360.00% EPS growth.

Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.02, from 0.94 in 2017Q2. It increased, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Vestor Limited Liability Co, Illinois-based fund reported 1,489 shares. Moreover, Vigilant Mngmt Ltd Liability Co has 0.21% invested in Pfizer Inc. (NYSE:PFE) for 39,042 shares. Wealthtrust invested 0.14% in Pfizer Inc. (NYSE:PFE). Partner Management Limited Partnership reported 31,061 shares or 1.05% of all its holdings. Liberty Mutual Group Asset Mngmt owns 245,839 shares for 0.48% of their portfolio. Highvista Strategies Llc owns 14,100 shares. Morgan Stanley owns 46.97 million shares for 0.5% of their portfolio. 36,282 were accumulated by Bridges Investment Counsel Inc. Woodley Farra Manion Port Mngmt reported 137,999 shares or 0.57% of all its holdings. 1St Source Bancorporation accumulated 151,375 shares. Comm Retail Bank holds 1.21% or 2.57M shares in its portfolio. Santa Barbara Asset Limited has invested 2.57% of its portfolio in Pfizer Inc. (NYSE:PFE). Croft has 96,816 shares. Trillium Asset Ltd accumulated 11,715 shares or 0.02% of the stock. Argyle Capital Management invested in 2.23% or 159,373 shares.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on January, 30. They expect $0.56 EPS, up 19.15% or $0.09 from last year’s $0.47 per share. PFE’s profit will be $3.34B for 16.31 P/E if the $0.56 EPS becomes a reality. After $0.67 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -16.42% negative EPS growth.

Among 21 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 11 Hold. Therefore 43% are positive. Pfizer had 67 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Wednesday, October 28 by Deutsche Bank. The stock has “Hold” rating by Berenberg on Thursday, May 12. The rating was maintained by Jefferies on Monday, October 16 with “Hold”. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Wednesday, August 16 by Jefferies. BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) on Monday, June 12 with “Hold” rating. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Argus Research on Tuesday, November 3. The rating was maintained by Piper Jaffray with “Overweight” on Saturday, September 5. BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) on Thursday, October 19 with “Outperform” rating. The firm has “Buy” rating by Cowen & Co given on Monday, August 14. UBS maintained Pfizer Inc. (NYSE:PFE) rating on Wednesday, November 1. UBS has “Buy” rating and $38.0 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts